AI-generated summary
The authors report a systematic review and meta-analysis of eight studies (five randomized trials and three non-randomized studies) examining photobiomodulation therapy for acute radiation dermatitis in patients with cancer. They found that the therapy group had a lower incidence of grade 2 and 3 dermatitis than controls, with the authors noting this may benefit patients with breast and head and neck cancer. The authors caution that high heterogeneity among studies means the results should be interpreted carefully.
- Studies included
- 8
- Who or what was studied
- Patients with cancer receiving radiotherapy who developed acute radiation dermatitis
- Limits stated in the abstract
- The authors state that the included studies showed high heterogeneity and that results must be interpreted with caution.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Systematic review, Control group, Meta-analysis, Confidence interval, Heterogeneity, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.